Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35931| Title: | Serum soluble Fas and Fas ligand (FasL) in primary Sjogren's syndrome. | Authors: | Morand E.F. ;Rischmueller M.;Vincent F.B. ;Bubicich M.;Downie-Doyle S.;Mackay F. | Institution: | (Bubicich, Downie-Doyle, Rischmueller) Rheumatology Department, Queen Elizabeth Hospital, Woodville, SA, Australia (Mackay) Department of Immunology and Pathology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), Melbourne, Australia (Mackay) Department of Microbiology and Immunology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia (Rischmueller) Discipline of Medicine, University of Adelaide, Australia (Vincent, Morand) Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash Medical Centre, 246 Clayton Rd, Clayton, VIC 3168, Australia | Issue Date: | 30-Sep-2019 | Copyright year: | 2019 | Publisher: | Clinical and Experimental Rheumatology S.A.S. (via Santa Maria 31, Pisa 56126, Italy. E-mail: info@clinexprheumatol.org) | Place of publication: | Italy | Publication information: | Clinical and Experimental Rheumatology. 37 (Supplement3) (pp S254-S256), 2019. Date of Publication: 2019. | Journal: | Clinical and Experimental Rheumatology | PubMed URL: | 30789150 [http://www.ncbi.nlm.nih.gov/pubmed/?term=30789150] | ISSN: | 0392-856X | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/35931 | Type: | Letter | Type of Clinical Study or Trial: | Opinion, perspective or news |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.